TY - JOUR
T1 - Author Correction
T2 - Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study (Nature Medicine, (2026), 32, 1, (197-223), 10.1038/s41591-025-04077-9)
AU - GBD 2023 Global Chronic Respiratory Disease and Covid Collaborators
AU - Oh, Jiyeon
AU - Kim, Soeun
AU - Yim, Yesol
AU - Kim, Min Seo
AU - Zyoud, Samer H.
AU - Zyoud, Sa’ed H.
AU - Zoghi, Ghazal
AU - Zitoun, Osama A.
AU - Zielińska, Magdalena
AU - Zia, Hafsa
AU - Zhumagaliuly, Abzal
AU - Zhu, Bin
AU - Zhou, Jiayan
AU - Zhong, Claire Chenwen
AU - Zaki, Nazar
AU - Talaat, Iman M.
AU - Soliman, Sameh S.M.
AU - Shamsi, Anas
AU - Shahwan, Moyad Jamal
AU - Sengupta, Pallav
AU - Saleh, Mohamed A.
AU - Saddik, Basema Ahmad
AU - Saber-Ayad, Maha Mohamed
AU - Nauman, Javaid
AU - Momani, Shaher
AU - Manla, Yosef
AU - Khan, Moien A.B.
AU - Khalifa, Hazim O.
AU - Hassan, Nageeb
AU - Halwani, Rabih
AU - Grivna, Michal
AU - Elemam, Noha Mousaad
AU - Eladl, Mohamed Ahmed
AU - Dababo, Nour
AU - Bustanji, Yasser
AU - Bhagavathula, Akshaya Srikanth
AU - Bernstein, Robert S.
AU - Ashames, Akram
AU - Arumugam, Ashokan
AU - Arafat, Mosab
AU - Arafa, Elshaimaa A.
AU - Amin, Amr
AU - Alzoubi, Karem H.
AU - Alzoubi, Abdallah
AU - Al-Worafi, Yaser Mohammed
AU - Altirkawi, Khalid A.
AU - Al-Ajlouni, Yazan
AU - Acuna, Juan Manuel
AU - Aburuz, Salahdein
AU - Abu-Gharbieh, Eman
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature America, Inc. 2026.
PY - 2026/3
Y1 - 2026/3
N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04077-9, published online 6 January. In the version of the article initially published, there was an error in the last sentence of the abstract, where in the text now reading “During the pandemic, the incidence of chronic respiratory diseases increased modestly, but the decline in mortality rates became less pronounced,” “became less pronounced” appeared as “became more pronounced.” In the Results “Disease burden before and during the COVID-19 pandemic” section, a similar error appeared, and some average annual percentage change values were mistakenly interchanged. In the updated text that follows, the original incorrect text or values are shown in brackets. “In contrast, the AAPC of age-standardized death rates of chronic respiratory diseases showed a less [more] pronounced decreasing trend during the pandemic (AAPC, –1.23 [−3.04]) compared with before the pandemic (AAPC, –3.04 [−1.23]; Extended Data Fig. 9). This pattern in mortality trends was also observed for COPD, for which the AAPC in deaths changed from –3.27 to –1.34 [−1.34 to −3.27]. Similarly, asthma showed a shift in death rates from –1.92 to –1.26 [–1.26 to –1.92], whereas asthma … the pandemic). Pneumoconiosis showed a reversing trend in mortality from a decline before the pandemic (AAPC, 0.21 [−1.26]) to a minimal increase (AAPC, –1.26 [0.21]) during the pandemic…. For ILD and pulmonary sarcoidosis, mortality trends reversed from a modest increase (AAPC, –1.99 [1.05]) to a slight decline (AAPC, 1.05 [−1.99]; Fig. 4).” The text is now amended in the HTML and PDF versions of the article.
AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-04077-9, published online 6 January. In the version of the article initially published, there was an error in the last sentence of the abstract, where in the text now reading “During the pandemic, the incidence of chronic respiratory diseases increased modestly, but the decline in mortality rates became less pronounced,” “became less pronounced” appeared as “became more pronounced.” In the Results “Disease burden before and during the COVID-19 pandemic” section, a similar error appeared, and some average annual percentage change values were mistakenly interchanged. In the updated text that follows, the original incorrect text or values are shown in brackets. “In contrast, the AAPC of age-standardized death rates of chronic respiratory diseases showed a less [more] pronounced decreasing trend during the pandemic (AAPC, –1.23 [−3.04]) compared with before the pandemic (AAPC, –3.04 [−1.23]; Extended Data Fig. 9). This pattern in mortality trends was also observed for COPD, for which the AAPC in deaths changed from –3.27 to –1.34 [−1.34 to −3.27]. Similarly, asthma showed a shift in death rates from –1.92 to –1.26 [–1.26 to –1.92], whereas asthma … the pandemic). Pneumoconiosis showed a reversing trend in mortality from a decline before the pandemic (AAPC, 0.21 [−1.26]) to a minimal increase (AAPC, –1.26 [0.21]) during the pandemic…. For ILD and pulmonary sarcoidosis, mortality trends reversed from a modest increase (AAPC, –1.99 [1.05]) to a slight decline (AAPC, 1.05 [−1.99]; Fig. 4).” The text is now amended in the HTML and PDF versions of the article.
UR - https://www.scopus.com/pages/publications/105033952094
U2 - 10.1038/s41591-026-04288-8
DO - 10.1038/s41591-026-04288-8
M3 - Comment/debate
C2 - 41814008
AN - SCOPUS:105033952094
SN - 1078-8956
VL - 32
SP - 1160
JO - Nature Medicine
JF - Nature Medicine
IS - 3
ER -